SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alembic Pharmaceuticals informs about board meeting

07 May 2018 Evaluate

Alembic Pharmaceuticals has informed that a Meeting of Board of Directors of the Company shall be held on 16th May, 2018, to consider and approve Audited Financial Results of the Company for the financial year ended 31st March, 2018; to consider and recommend dividend on Equity Shares, if any, for the financial year ended 31st March, 2018. The trading window shall remain closed from 13th May, 2018 to 18th May, 2018 for the above referred purpose.

The above information is a part of company’s filings submitted to BSE.

 

Alembic Pharma Share Price

750.00 -19.80 (-2.57%)
24-Apr-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1618.50
Dr. Reddys Lab 1312.40
Cipla 1295.00
Zydus Lifesciences 930.00
Lupin 2285.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×